Skip to Content
We are here to provide the care you need. Our centers of care are experiencing high volumes and long wait times. Learn about your care options. Currently, no routine visitors are allowed at the hospital or at any outpatient care centers.

Sarcoma Cancer Trials

​A091902: A Multicenter Phase II Trial of Paclitaxel with and without Nivolumab in Taxane Naive, and Nivolumab and Cabozantinib in Taxane Pretreated Subjects with Angiosarcoma
Aims: The purpose of this study is to see the good and bad effects of adding  Nivolumab immunotherapy to Taxol chemotherapy.
Diagnosis: angio-sarcoma
Principal Investigator: Bruce Brockstein, MD
IRB Approval Number: EH20-414
Sponsor: Alliance for Clinical Trials in Oncology
Contact: Interested patients should contact research nurse Michele Britto, RN at 847.570.2109
Open to Enrollment: Yes

 

Ayala AL-DES-01: A Phase 2/3, Randomized, Multicenter Study to Evaluate AL 102 in Paitents iwth Progressing Desmoid Tumors
Aims: The purpose of this study is to see the good and bad effects of using the investigational drug called AL102 to treat desmoid tumors.
Diagnosis: Desmoid tumors
Principal Investigator: Bruce Brockstein, MD
IRB Approval Number: EH21-180
Sponsor: Ayala Pharmaceuticals, Inc.
Contact: Interested patients should contact research nurse Michele Britto, RN at 847.570.2109
Open to Enrollment: Yes